<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> and related metabolic alterations have been implicated to play a role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, as assessed according to current international definitions by the key components, abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, elevated blood pressure, and abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, is associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies suggest that abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> and abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism may primarily account for this association </plain></SENT>
<SENT sid="3" pm="."><plain>Visceral adipose tissue is physiologically more active than subcutaneous adipose tissue and generates hormones and cytokines with inflammatory, metabolic, and direct carcinogenic potential, which may directly or indirectly increase <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="4" pm="."><plain>Current evidence suggests that <z:hpo ids='HP_0001513'>obesity</z:hpo> acts as a risk factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> by several mechanisms, including <z:hpo ids='HP_0011010'>chronic</z:hpo> low-grade <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, as well as alterations in insulin-like growth factor and adipokine concentrations </plain></SENT>
<SENT sid="5" pm="."><plain>Metabolic biomarkers reflecting these processes may not only provide clues for etiological understanding of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> but also might be an alternative way to define an "<z:hpo ids='HP_0001513'>obesity</z:hpo> phenotype" that is relevant for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development </plain></SENT>
</text></document>